Gonadotropin-Secreting Pituitary Macroadenoma Complicated With Hemorrhagic Apoplexy in 18F-FDG PET/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Sep 2021
01 Sep 2021
Historique:
pubmed:
26
5
2021
medline:
16
10
2021
entrez:
25
5
2021
Statut:
ppublish
Résumé
We report the case of 69-year-old man referred for a stage IV pulmonary adenocarcinoma and presenting a decrease in visual acuity. An 18F-FDG PET/CT showed an intense and heterogeneous uptake of a mass in the sellar region. An MRI showed a pituitary macroadenoma associated with a large cyst on the left side, with necrosis zones and fluid level, compressing the optic chiasma. Endocrine testing showed a panhypopituitarism, and pathology confirmed a pituitary apoplexy in a gonadotropin-secreting macroadenoma. No malignant cells were detected. Molecular imaging could have an important role in the detection and characterization of pituitary tumors.
Identifiants
pubmed: 34034313
doi: 10.1097/RLU.0000000000003710
pii: 00003072-202109000-00009
doi:
Substances chimiques
Gonadotropins
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
748-749Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declare.
Références
Solinas C, Porcu M, De Silva P, et al. Cancer immunotherapy-associated hypophysitis. Semin Oncol . 2018;45:181–186.
Baglin G, Betermiez P, Bertout A, et al. Apoplexie hypophysaire et baisse d’acuité visuelle bilatérale sévère : à propos d’un cas. J Fr Ophtalmol . 2009;32:572–576.
Campeau RJ, David O, Dowling AM. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med . 2003;28:296–298.
Oldfield EH, Merrill MJ. Apoplexy of pituitary adenomas: the perfect storm. J Neurosurg . 2015;122:1444–1449.
Hyun SH, Choi JY, Lee KH, et al. Incidental focal 18 F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med . 2011;52:547–550.
Jeong SY, Lee SW, Lee HJ, et al. Incidental pituitary uptake on whole-body 18 F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging . 2010;37:2334–2343.
Piciu A, Mester A, Piciu D. Pituitary metastases discovered by 18 F-FDG PET/CT during other cancers monitoring: are there any differences of SUVs between benign and malignant diseases? Clin Nucl Med . 2021;46:e44–e46.
Ju H, Zhou J, Pan Y, et al. Evaluation of pituitary uptake incidentally identified on 18 F-FDG PET/CT scan. Oncotarget . 2017;8:55544–55549.
Iglesias P, Cardona J, Díez JJ. The pituitary in nuclear medicine imaging. Eur J Intern Med . 2019;68:6–12.
Chen X, Chen G, Fu Z, et al. 18 F-FDG PET/CT findings in a patient with neurosarcoidosis. Clin Nucl Med . 2020;45:640–641.
Ishizaki U, Abe K, Takako K, et al. FDG PET/CT findings of ectopic pituitary adenoma. Clin Nucl Med . 2020;45:151–153.
Kong Z, Wang Y, Ma W, et al. FDG PET/CT image for a Rosai-Dorfman disease with pituitary and bone involvement in a pediatric patient. Clin Nucl Med . 2019;44:873–875.
Boyle J, Patronas NJ, Smirniotopoulos J, et al. CRH stimulation improves 18 F-FDG-PET detection of pituitary adenomas in Cushing’s disease. Endocrine . 2019;65:155–165.
Heimburger C, Bund C, Addeo P, et al. 18 F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma. Clin Nucl Med . 2018;43:e324–e325.
Vauchot F, Bourdon A, Hay B, et al. Therapeutic response to rituximab in IgG4-related hypophysitis evidenced on 18 F-FDG PET and MRI. Clin Nucl Med . 2019;44:e362–e363.
Zhao X, Xiao J, Xing B, et al. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy. Clin Nucl Med . 2014;39:605–608.